Eli Zuckerman

10.2k citations
79 papers · 2.8k · 1 hit paper · h-index 27

Impact in

  • Hepatology top 0.2%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis C virus research 42
    • Liver Disease and Transplantation 8
    • Hepatocellular Carcinoma Treatment and Prognosis 3
    • Liver Disease Diagnosis and Treatment 19
    • Hepatitis B Virus Studies 15

Eli Zuckerman

78 papers receiving 2.7k citations

Eli Zuckerman's Hit Papers

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study 2015 · 493 citations
4930+3+7Years since publication100200300400

Peers

Eli Zuckerman
Comparison fields: 5 of 102
  • Hepatology 1.8k
  • Epidemiology 1.1k
  • Rheumatology 400
  • Genetics 237
  • Transplantation 49
Replace Aurélie Plessier with:
Aurélie Plessier France
Jérôme Le Pavec France
Bertrand Condat France
J.A.C. Buckels United Kingdom
Frédéric Gauthier France
Deborah K. Freese United States
Christophe Bureau France
Dorothy M. Painter Australia
Catherine Buffet France
Alan W. Hemming United States
Eli Zuckerman relative to Aurélie Plessier France Aurélie Plessier's profile →
Citations per field
00.5×2.9×
Aurélie Plessier · 1×
Citations per year

Countries citing papers authored by Eli Zuckerman

Since Specialization
Citations

This map shows the geographic impact of Eli Zuckerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Zuckerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Zuckerman more than expected).

Fields of papers citing papers by Eli Zuckerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Zuckerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Zuckerman. The network helps show where Eli Zuckerman may publish in the future.

Co-authors

The 25 scholars most cited alongside Eli Zuckerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eli Zuckerman Line = papers co-authored together Eli Zuckerman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
Hit paper breakdown →
2015493
2 1997326
3
Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha.
2000127
4 2015113
5 199594
6 199890
7 200188
8 201580
9 199677
10 199671
11 199866
12 200464
13 200459
14 199858
15 199955
16 200151
17 200248
18
Aortic involvement in rheumatic diseases.
200647
19 200145
20 200140

About Eli Zuckerman

Eli Zuckerman is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Surgery and Genetics, having authored 79 papers that have together received 2.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (42 papers), Liver Disease Diagnosis and Treatment (19 papers), Hepatitis B Virus Studies (15 papers), Systemic Lupus Erythematosus Research (8 papers), Liver Disease and Transplantation (8 papers), Chronic Lymphocytic Leukemia Research (8 papers), HIV/AIDS drug development and treatment (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Hepatology (1.8k citations), Epidemiology (1.1k citations), Rheumatology (400 citations), Genetics (237 citations) and Transplantation (49 citations). Eli Zuckerman has collaborated with scholars based in Israel, United States and Spain. Frequent co-authors include Daniel Yeshurun, Elias Toubi, Tsila Zuckerman, Gleb Slobodin, Edmond Sabo, Janice Wahl, Michael Robertson, Jochanan E. Naschitz, Aharon Kessel and Michael Rozenbaum. Their work appears in journals such as Journal of Hepatology, The American Journal of Gastroenterology, Journal of Virology, Liver International and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact